share_log

Wedbush Reiterates Outperform on IGM Biosciences, Maintains $20 Price Target

Moomoo 24/7 ·  Mar 8 10:11

Wedbush analyst Robert Driscoll reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment